Literature DB >> 21712493

Minimal modeling approaches to value of information analysis for health research.

David O Meltzer1,2,3, Ties Hoomans1, Jeanette W Chung1, Anirban Basu1.   

Abstract

Value of information (VOI) techniques can provide estimates of the expected benefits from clinical research studies that can inform decisions about the design and priority of those studies. Most VOI studies use decision-analytic models to characterize the uncertainty of the effects of interventions on health outcomes, but the complexity of constructing such models can pose barriers to some practical applications of VOI. However, because some clinical studies can directly characterize uncertainty in health outcomes, it may sometimes be possible to perform VOI analysis with only minimal modeling. This article 1) develops a framework to define and classify minimal modeling approaches to VOI, 2) reviews existing VOI studies that apply minimal modeling approaches, and 3) illustrates and discusses the application of the minimal modeling to 2 new clinical applications to which the approach appears well suited because clinical trials with comprehensive outcomes provide preliminary estimates of the uncertainty in outcomes. The authors conclude that minimal modeling approaches to VOI can be readily applied in some instances to estimate the expected benefits of clinical research.

Mesh:

Year:  2011        PMID: 21712493     DOI: 10.1177/0272989X11412975

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  20 in total

1.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

2.  Health Departments' Engagement in Emergency Preparedness Activities: The Influence of Health Informatics Capacity.

Authors:  Gulzar H Shah; Bobbie Newell; Ruth E Whitworth
Journal:  Int J Health Policy Manag       Date:  2016-10-01

3.  The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

4.  Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.

Authors:  David D Kim; Gregory F Guzauskas; Caroline S Bennette; Anirban Basu; David L Veenstra; Scott D Ramsey; Josh J Carlson
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

5.  Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.

Authors:  Caroline S Bennette; David L Veenstra; Anirban Basu; Laurence H Baker; Scott D Ramsey; Josh J Carlson
Journal:  Med Decis Making       Date:  2016-03-24       Impact factor: 2.583

6.  Burden of illness and research investments in translational sciences for pharmaceuticals in metastatic cancers.

Authors:  Wei-Jhih Wang; Justin C Robertson; Anirban Basu
Journal:  J Comp Eff Res       Date:  2016-12-09       Impact factor: 1.744

7.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

8.  Road map to a patient-centered research agenda at the intersection of hospital medicine and geriatric medicine.

Authors:  Heidi L Wald; Luci K Leykum; Melissa L P Mattison; Eduard E Vasilevskis; David O Meltzer
Journal:  J Gen Intern Med       Date:  2014-06       Impact factor: 5.128

9.  Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

Authors:  Katrina Abuabara; Joy Wan; Andrea B Troxel; Daniel B Shin; Abby S Van Voorhees; Bruce F Bebo; Gerald G Krueger; Kristina Callis Duffin; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-08-19       Impact factor: 11.527

10.  Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.

Authors:  Josh J Carlson; Rahber Thariani; Josh Roth; Julie Gralow; N Lynn Henry; Laura Esmail; Pat Deverka; Scott D Ramsey; Laurence Baker; David L Veenstra
Journal:  Med Decis Making       Date:  2013-05       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.